Discovery and synthesis of a novel and selective drug-like P2X(1) antagonist
Although there is extensive literature to indicate that many different types of P2 purinoceptors are present in the lower urinary tract, the physiological role of these receptors in micturition is still uncertain. In part, this uncertainty has been caused by a lack of P2 subtype selective ligands. I...
Gespeichert in:
| Veröffentlicht in: | Bioorganic & medicinal chemistry letters 2005-07, Vol.15 (13), p.3292 |
|---|---|
| Hauptverfasser: | , , , , , |
| Format: | Artikel |
| Sprache: | eng |
| Schlagworte: | |
| Online-Zugang: | Volltext |
| Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
| container_end_page | |
|---|---|
| container_issue | 13 |
| container_start_page | 3292 |
| container_title | Bioorganic & medicinal chemistry letters |
| container_volume | 15 |
| creator | Jaime-Figueroa, S Greenhouse, R Padilla, F Dillon, M P Gever, J R Ford, A P D W |
| description | Although there is extensive literature to indicate that many different types of P2 purinoceptors are present in the lower urinary tract, the physiological role of these receptors in micturition is still uncertain. In part, this uncertainty has been caused by a lack of P2 subtype selective ligands. In this paper we report the discovery, gram scale synthesis, and binding results for 1, the first potent, drug-like, selective P2X(1) receptor antagonist described. Compound 1 was shown to be more than 30-fold selective over other purinergic receptor subtypes. |
| doi_str_mv | 10.1016/j.bmcl.2005.04.049 |
| format | Article |
| fullrecord | <record><control><sourceid>pubmed</sourceid><recordid>TN_cdi_pubmed_primary_15927468</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>15927468</sourcerecordid><originalsourceid>FETCH-LOGICAL-p139t-a8f8cd81887c28d87d098e6b1d49490d03cd67a498a21342ca3e434b66cecfe53</originalsourceid><addsrcrecordid>eNo1z09LwzAYBvAcFDenX8CD5KiH1jfJ2zQ5ypx_oKAHhd1GmqQzs2tL0w367S1M4YHn8IMHHkJuGKQMmHzYpeXe1ikHyFLAKfqMzEFLSJTG9YxcxrgDYAiIF2TGMs1zlGpOiqcQbXv0_UhN42gcm-HbxxBpW1FDm0nqE_ja2yEcPXX9YZvU4cfTD76-Y_cTD2bbNiEOV-S8MnX013-9IF_Pq8_la1K8v7wtH4ukY0IPiVGVsk4xpXLLlVO5A628LJlDjRocCOtkblArw5lAbo3wKLCU0npb-UwsyO1ptzuUe-82XR_2ph83_7fEL1gJTiw</addsrcrecordid><sourcetype>Index Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype></control><display><type>article</type><title>Discovery and synthesis of a novel and selective drug-like P2X(1) antagonist</title><source>MEDLINE</source><source>Elsevier ScienceDirect Journals Complete</source><creator>Jaime-Figueroa, S ; Greenhouse, R ; Padilla, F ; Dillon, M P ; Gever, J R ; Ford, A P D W</creator><creatorcontrib>Jaime-Figueroa, S ; Greenhouse, R ; Padilla, F ; Dillon, M P ; Gever, J R ; Ford, A P D W</creatorcontrib><description>Although there is extensive literature to indicate that many different types of P2 purinoceptors are present in the lower urinary tract, the physiological role of these receptors in micturition is still uncertain. In part, this uncertainty has been caused by a lack of P2 subtype selective ligands. In this paper we report the discovery, gram scale synthesis, and binding results for 1, the first potent, drug-like, selective P2X(1) receptor antagonist described. Compound 1 was shown to be more than 30-fold selective over other purinergic receptor subtypes.</description><identifier>ISSN: 0960-894X</identifier><identifier>DOI: 10.1016/j.bmcl.2005.04.049</identifier><identifier>PMID: 15927468</identifier><language>eng</language><publisher>England</publisher><subject>Amides - chemical synthesis ; Amides - pharmacology ; Animals ; Calcium - analysis ; Cell Line ; Cell Survival ; Humans ; Inhibitory Concentration 50 ; Ligands ; Purinergic P2 Receptor Antagonists ; Receptors, Purinergic P2X ; Structure-Activity Relationship ; Transfection</subject><ispartof>Bioorganic & medicinal chemistry letters, 2005-07, Vol.15 (13), p.3292</ispartof><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>314,780,784,27924,27925</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/15927468$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Jaime-Figueroa, S</creatorcontrib><creatorcontrib>Greenhouse, R</creatorcontrib><creatorcontrib>Padilla, F</creatorcontrib><creatorcontrib>Dillon, M P</creatorcontrib><creatorcontrib>Gever, J R</creatorcontrib><creatorcontrib>Ford, A P D W</creatorcontrib><title>Discovery and synthesis of a novel and selective drug-like P2X(1) antagonist</title><title>Bioorganic & medicinal chemistry letters</title><addtitle>Bioorg Med Chem Lett</addtitle><description>Although there is extensive literature to indicate that many different types of P2 purinoceptors are present in the lower urinary tract, the physiological role of these receptors in micturition is still uncertain. In part, this uncertainty has been caused by a lack of P2 subtype selective ligands. In this paper we report the discovery, gram scale synthesis, and binding results for 1, the first potent, drug-like, selective P2X(1) receptor antagonist described. Compound 1 was shown to be more than 30-fold selective over other purinergic receptor subtypes.</description><subject>Amides - chemical synthesis</subject><subject>Amides - pharmacology</subject><subject>Animals</subject><subject>Calcium - analysis</subject><subject>Cell Line</subject><subject>Cell Survival</subject><subject>Humans</subject><subject>Inhibitory Concentration 50</subject><subject>Ligands</subject><subject>Purinergic P2 Receptor Antagonists</subject><subject>Receptors, Purinergic P2X</subject><subject>Structure-Activity Relationship</subject><subject>Transfection</subject><issn>0960-894X</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2005</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><recordid>eNo1z09LwzAYBvAcFDenX8CD5KiH1jfJ2zQ5ypx_oKAHhd1GmqQzs2tL0w367S1M4YHn8IMHHkJuGKQMmHzYpeXe1ikHyFLAKfqMzEFLSJTG9YxcxrgDYAiIF2TGMs1zlGpOiqcQbXv0_UhN42gcm-HbxxBpW1FDm0nqE_ja2yEcPXX9YZvU4cfTD76-Y_cTD2bbNiEOV-S8MnX013-9IF_Pq8_la1K8v7wtH4ukY0IPiVGVsk4xpXLLlVO5A628LJlDjRocCOtkblArw5lAbo3wKLCU0npb-UwsyO1ptzuUe-82XR_2ph83_7fEL1gJTiw</recordid><startdate>20050701</startdate><enddate>20050701</enddate><creator>Jaime-Figueroa, S</creator><creator>Greenhouse, R</creator><creator>Padilla, F</creator><creator>Dillon, M P</creator><creator>Gever, J R</creator><creator>Ford, A P D W</creator><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope></search><sort><creationdate>20050701</creationdate><title>Discovery and synthesis of a novel and selective drug-like P2X(1) antagonist</title><author>Jaime-Figueroa, S ; Greenhouse, R ; Padilla, F ; Dillon, M P ; Gever, J R ; Ford, A P D W</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-p139t-a8f8cd81887c28d87d098e6b1d49490d03cd67a498a21342ca3e434b66cecfe53</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2005</creationdate><topic>Amides - chemical synthesis</topic><topic>Amides - pharmacology</topic><topic>Animals</topic><topic>Calcium - analysis</topic><topic>Cell Line</topic><topic>Cell Survival</topic><topic>Humans</topic><topic>Inhibitory Concentration 50</topic><topic>Ligands</topic><topic>Purinergic P2 Receptor Antagonists</topic><topic>Receptors, Purinergic P2X</topic><topic>Structure-Activity Relationship</topic><topic>Transfection</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Jaime-Figueroa, S</creatorcontrib><creatorcontrib>Greenhouse, R</creatorcontrib><creatorcontrib>Padilla, F</creatorcontrib><creatorcontrib>Dillon, M P</creatorcontrib><creatorcontrib>Gever, J R</creatorcontrib><creatorcontrib>Ford, A P D W</creatorcontrib><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><jtitle>Bioorganic & medicinal chemistry letters</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Jaime-Figueroa, S</au><au>Greenhouse, R</au><au>Padilla, F</au><au>Dillon, M P</au><au>Gever, J R</au><au>Ford, A P D W</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Discovery and synthesis of a novel and selective drug-like P2X(1) antagonist</atitle><jtitle>Bioorganic & medicinal chemistry letters</jtitle><addtitle>Bioorg Med Chem Lett</addtitle><date>2005-07-01</date><risdate>2005</risdate><volume>15</volume><issue>13</issue><spage>3292</spage><pages>3292-</pages><issn>0960-894X</issn><abstract>Although there is extensive literature to indicate that many different types of P2 purinoceptors are present in the lower urinary tract, the physiological role of these receptors in micturition is still uncertain. In part, this uncertainty has been caused by a lack of P2 subtype selective ligands. In this paper we report the discovery, gram scale synthesis, and binding results for 1, the first potent, drug-like, selective P2X(1) receptor antagonist described. Compound 1 was shown to be more than 30-fold selective over other purinergic receptor subtypes.</abstract><cop>England</cop><pmid>15927468</pmid><doi>10.1016/j.bmcl.2005.04.049</doi></addata></record> |
| fulltext | fulltext |
| identifier | ISSN: 0960-894X |
| ispartof | Bioorganic & medicinal chemistry letters, 2005-07, Vol.15 (13), p.3292 |
| issn | 0960-894X |
| language | eng |
| recordid | cdi_pubmed_primary_15927468 |
| source | MEDLINE; Elsevier ScienceDirect Journals Complete |
| subjects | Amides - chemical synthesis Amides - pharmacology Animals Calcium - analysis Cell Line Cell Survival Humans Inhibitory Concentration 50 Ligands Purinergic P2 Receptor Antagonists Receptors, Purinergic P2X Structure-Activity Relationship Transfection |
| title | Discovery and synthesis of a novel and selective drug-like P2X(1) antagonist |
| url | https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-03T02%3A16%3A17IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-pubmed&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Discovery%20and%20synthesis%20of%20a%20novel%20and%20selective%20drug-like%20P2X(1)%20antagonist&rft.jtitle=Bioorganic%20&%20medicinal%20chemistry%20letters&rft.au=Jaime-Figueroa,%20S&rft.date=2005-07-01&rft.volume=15&rft.issue=13&rft.spage=3292&rft.pages=3292-&rft.issn=0960-894X&rft_id=info:doi/10.1016/j.bmcl.2005.04.049&rft_dat=%3Cpubmed%3E15927468%3C/pubmed%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_id=info:pmid/15927468&rfr_iscdi=true |